Delivery Order SPE2DB20D1109-SPE2DB22FN97L
Award Date 4/8/22
Potential Completion Date 4/11/22
Potential Value $45K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,552,571,927 units of the prescription medication Vyvanse 30 mg capsules. The award, valued at $16,943.75, was made by the Defense Logistics Agency (DLA) on February 19, 2021, with a completion date of February 22, 2021. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides $1,841.30 for the delivery of Vyvanse 30 mg capsules to support the Defense Logistics Agency (DLA) Troop Support Medical. The award, with an ultimate completion date of April 24, 2023, is structured as a firm fixed-price Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,562,306,642 units of Vyvanse 70 mg capsules. The firm-fixed-price delivery order, valued at $1,964.75, has an ultimate completion date of September 27, 2023. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,560,970,387 units of Vyvanse 30 mg capsule. The contract has a firm fixed price of $1,634.63 and an ultimate completion date of May 18, 2023. This is a delivery order contract and is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00. The contract covers the delivery of 4,563,617,369 units of Vyvanse 30 mg capsules, a specialty medication, to support military and veterans' healthcare programs. The award has a ceiling value of $1,755.19 and an ultimate completion date of February 12, 2024. The...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,696.58 for the supply of Vyvanse 40 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 13, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,347.36 for the supply of Vyvanse 50 mg capsules. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,833.42 firm fixed-price delivery order is for the supply of 4,562,216,918 units of the pharmaceutical drug Vyvanse 60 mg capsules. The contract has a period of performance through September 19, 2023 and was awarded on September 18, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4551548057 units of Vyvanse 30 mg capsules. The $2,264.97 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to supply a comprehensive range of...
- This federal contract award, valued at $1,051.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,587,061 units of the prescription medication Vyvanse 20 mg capsules. The award is classified as a Delivery Order under a Firm Fixed Price contract type, with a completion date of February 8, 2024. This contract is not designated as a set-aside procurement. Amerisourcebergen Drug Corp is a major...